💊Takeda Statement Regarding Shire
March 28, 2018 Cambridge, Mass. and Osaka, Japan
Takeda Pharmaceutical Company Limited (“Takeda”) notes the share price movement with respect to Shire plc (“Shire”).
Takeda confirms that it is considering making an approach to Shire regarding a possible offer for the company.
Takeda’s consideration of such an offer is at a preliminary and exploratory stage and no approach has been made to the Board of Shire. There can be no certainty that an approach, if made, will lead to any transaction.
https://www.takeda.com/newsroom/newsreleases/2018/takeda-statement-regarding-shire/